Centrus Energy Corp. research snapshot
LEU AI stock analysis as of the August 4, 2026 data cutoff reads Centrus Energy as the only US-headquartered HALEU-capable uranium enrichment company with a signed $900 million DOE contract, a growing commercial pipeline, and a stock that has recovered from its $142.13 52-week low to about $185.89. The stock still sits roughly 60% below the October 2025 high of $464.25, and the LEU AI stock forecast uses scenario ranges because revenue is lumpy, TTM free cash flow is negative during the HALEU commercial transition, and the forward PE near 82x prices in a successful cascade scale-up. The variables that matter most are DOE contract execution, HALEU production milestones, enrichment pricing, competition from Urenco and Orano, and balance-sheet strength.
Current price
$185.89 (Aug 3, 2026 close)
Market cap
$3.66 billion verified market cap
AI score
56 / 100
Rating
Uranium enrichment pure-play with DOE HALEU contract momentum and a rebound off the low, but high valuation and binary execution risk remain
Trend status
Rebounded from the $142.13 52-week low to trade above the 20, 50, and 100-day moving averages, still below the 200-day moving average near $229
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Centrus sells enriched uranium fuel and enrichment services to nuclear power utilities and government customers, with a signed $900 million DOE HALEU contract and a commercial pipeline that includes an Oklo letter of intent. | Medium |
| Moat | NRC licenses, DOE relationships, HALEU first-mover position, US-origin enrichment know-how, and the planned commercial cascade create meaningful barriers, but Urenco, Orano, and emerging laser-enrichment competitors limit pricing power. | Medium |
| Management | Management signed the definitive DOE contract in July 2026, plans to transition the HALEU cascade to commercial operation, completed additional HALEU production ahead of schedule, and secured S&P SmallCap 600 inclusion, while managing a large cash and debt build tied to the DOE award. | Medium |
| Financial trend | FY2025 revenue was about $448.7 million with net income of $77.8 million. Q1 2026 revenue fell to $76.7 million with EPS of $0.45, and TTM free cash flow turned negative as the company invests in the HALEU cascade. Net cash stood at about $689.6 million at the end of Q1 2026. | Medium-high |
| Valuation | At $185.89, LEU trades near 65.5x TTM EPS, 7.95x sales, 4.49x book, and a forward PE near 81.8x, reflecting significant HALEU growth expectations with limited near-term earnings support. | Medium-high |
| Technical trend | The stock has rebounded above its 20, 50, and 100-day moving averages after testing the $142.13 low, but it remains below the 200-day moving average near $229, leaving the longer-term downtrend from the October 2025 high unresolved. | Medium |
| Risk level | Main risks are DOE funding and contract execution, HALEU scale-up delays, enrichment price cyclicality, customer concentration, Urenco and Orano competition, high short interest near 25% of shares outstanding, and equity dilution. | Medium |
| AI confidence | Descriptive confidence is medium-high for current price, financials, valuation, and technical data. Forward return confidence is lower because the stock is driven by binary DOE contract catalysts and nuclear policy shifts. | Medium-high data confidence |
| Investment certainty | LEU is a strategically important nuclear fuel company with a signed DOE contract, but the current price embeds substantial HALEU optimism and execution risk remains material. | Low-to-medium |
LEU AI stock forecast
The LEU AI stock forecast is scenario-based because earnings depend on DOE HALEU contract execution, enrichment volumes, uranium market pricing, and commercial cascade scale-up. Using the $185.89 price reference, analyst consensus price targets spanning $170 to $390 with a $259.27 average, and the company current earnings power, the scenario ranges are roughly $280 to $390 in a bull case, $170 to $280 in a base case, and $80 to $165 in a bear case before dilution effects. The bull case requires successful HALEU commercialization, DOE funding continuity, and firm enrichment prices. The bear case materializes if DOE milestones slip, funding is reduced, enrichment prices weaken, competition captures share, or the company needs dilutive financing.
$280 to $390 before dilution effects
More likely if the DOE HALEU contract converts to commercial production revenue, the Oklo letter of intent becomes a firm order, enrichment prices stay firm, DOE funding continues, and Centrus delivers positive free cash flow from the Ohio enrichment cascade.
$170 to $280 before dilution effects
More likely if HALEU production ramps gradually, enrichment margins stay stable, the LEU segment generates steady cash flow, and the market holds the stock near the analyst consensus range.
$80 to $165 before dilution effects
More likely if DOE contract milestones slip, funding gets reduced, enrichment prices decline, Urenco or Orano capture HALEU market share, or Centrus requires dilutive equity financing.
LEU AI technical analysis
LEU AI technical analysis as of the August 3, 2026 close shows a stock recovering from a deep correction. LEU traded near $185.89, above its 20, 50, and 100-day moving averages but below the 200-day moving average near $229. The 52-week range is $142.13 to $464.25, the 14-day RSI is near 57.7, and 14-day historical volatility remains elevated near 84%.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $185.89 | StockAnalysis listed the Aug 3, 2026 close near $185.89, up 5.06% on the day after the stock recovered from the $142.13 low. |
| Immediate support | $170 to $176 | The 50-day moving average near $170.57 and the prior close near $176.93 sit in this zone. A hold above the 50-day average keeps the recovery intact. |
| Deeper support | $142 to $155 | The 52-week low of $142.13 marks the critical floor. A break below it would put LEU at new lows and signal the rebound has failed. |
| Near resistance | $195 to $210 | This zone represents the recent swing area and round-number resistance. A clean reclaim above $210 would improve short-term momentum. |
| Upper resistance | $229 to $260 | The 200-day moving average near $229.06 and the analyst median target near $264 define the main overhead supply for the stock. |
| Moving averages | Above the 20, 50, and 100-day; below the 200-day | The short and medium moving averages have turned up, but the 200-day average near $229 still defines a longer-term downtrend. A full trend reversal needs the 50-day to keep rising toward the 200-day. |
| Momentum | RSI near 57.7, stochastic near 95% | Momentum has improved after the oversold condition in July, but 14-day stochastic readings near 95% suggest the near-term move is extended and due for a pause. |
| Volume | Average volume near 817K to 832K shares | Volume has moderated from the October 2025 blowoff, and the rebound has occurred on ordinary volume. Watch for volume confirmation on any push above $210. |
| Volatility | ATR near $12.27 (about 6.6%), historical vol near 84% | Historic volatility and the average true range remain high, reflecting binary outcomes around DOE milestones and the August 5, 2026 earnings report. |
| Invalidation | Close below $142.13 | A sustained break below the 52-week low invalidates the recovery setup and would open a retest of lower support in the $100 to $130 zone. |
LEU AI trading strategy
The LEU AI trading strategy below is a rules-based research framework, not personal advice. It connects chart levels with DOE HALEU milestones, enrichment margins, the August 5, 2026 earnings report, order backlog, competitive dynamics, and uranium market conditions.
Wait for LEU to reclaim and hold above $210 with improving volume and positive DOE or customer contract news. A confirmed uptrend needs the 50-day moving average to keep rising and the stock to build a base above the $185 to $210 zone.
A failed reclaim followed by a break below $170 and then the $142.13 low invalidates the trend case, especially if paired with negative DOE or earnings news.
If LEU retests the $170 to $176 zone with declining downside volume, no new negative DOE news, and stable backlog data, the risk-reward for a tactical bounce improves, with RSI near 50 to 60 leaving room for a pullback to the 20 or 50-day average.
Do not treat a pullback as a value entry if DOE funding faces budget or political risk, if enrichment prices decline, or if the company signals a capital raise. Position sizing must account for high volatility and gap-down risk around earnings.
Track the August 5, 2026 Q2 earnings report, DOE HALEU milestones and funding announcements, enrichment services revenue, order backlog trends, competitor announcements from Urenco and Orano, and nuclear policy developments such as the DOE Nuclear Fuel Cycle Consortium and the US-Saudi nuclear agreement.
LEU is a binary catalyst-driven name with short interest near 25% of shares outstanding. Position sizing should reflect that a single DOE or earnings announcement can move the stock 20-40%, making standard stop-loss placement unreliable during event windows.
Investment research summary
Customers pay Centrus because nuclear power plants need licensed, reliable enriched uranium fuel, and Centrus is the only US-headquartered company with NRC-licensed enrichment technology and a signed DOE contract to transition HALEU production to commercial operation.
Centrus holds NRC licenses, DOE relationships, HALEU technology IP, engineering know-how, and a first-mover position in the US HALEU market. The moat is meaningful but not absolute, as Urenco, Orano, and emerging laser-enrichment technologies remain competitive alternatives.
The thesis fails if DOE funding is delayed or reduced, if Centrus cannot scale enrichment production on schedule, if enrichment prices decline, if larger competitors capture the HALEU market, or if the company needs dilutive financing to bridge the gap to commercial production.
Management signed the definitive $900 million DOE contract in July 2026, intends to transition the HALEU cascade to commercial operation, completed additional HALEU production ahead of schedule, and secured S&P SmallCap 600 inclusion. The critical test is converting contract backlog and HALEU scale-up into consistent operating cash flow without excessive dilution.
Nuclear power demand is rising on data-center electricity needs, AI energy consumption, corporate clean energy goals, and government energy-security policy, reinforced by the ban on Russian uranium imports, the DOE Nuclear Fuel Cycle Consortium, and a new US-Saudi nuclear agreement. The industry trend is favorable, but timing and execution remain the critical variables.
At $185.89, the stock trades near 65.5x TTM EPS and 7.95x sales with a forward PE near 82x, pricing in significant HALEU-driven growth while TTM free cash flow is negative. Margin of safety is limited unless the stock retests the $170 to $176 zone with intact DOE fundamentals, or the company delivers earnings and backlog growth that validates the current valuation.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| LEU quote reference | $185.89 close reference on Aug 3, 2026, up 5.06% on the day; 52-week range $142.13 to $464.25 | StockAnalysis LEU quote | August 4, 2026 |
| Market capitalization verification | $3.66 billion reported and $3.66 billion calculated from $185.89 x 19.67 million shares (0.10% deviation) | Pineify financial_rigor.py and StockAnalysis statistics | August 4, 2026 |
| Shares outstanding | 19.67 million shares outstanding, up 27.71% year over year | StockAnalysis statistics | August 4, 2026 |
| TTM and latest fiscal year revenue | TTM revenue about $452.3 million (down 4.05%); FY2025 revenue about $448.7 million (up 1.52%) | StockAnalysis financials | August 4, 2026 |
| Annual and TTM net income | FY2025 net income about $77.8 million; TTM net income about $60.6 million | StockAnalysis financials | August 4, 2026 |
| TTM valuation inputs | TTM EPS $2.85, PE 65.52, forward PE 81.84, PS 7.95, and PB 4.49 | StockAnalysis statistics | August 4, 2026 |
| Balance sheet position | Net cash about $689.6 million ($32.93 per share); cash and investments $1.87 billion; total debt $1.18 billion | StockAnalysis balance sheet | August 4, 2026 |
| Technical levels and volatility | 50-day MA $170.57, 200-day MA $229.06, RSI 57.65, 14-day ATR about $12.27, 14-day historical volatility near 83.6%, beta 1.36 | StockAnalysis statistics and Barchart technical analysis | August 4, 2026 |
| Analyst consensus | Buy rating from 17 analysts; average price target $259.27 with a range of $170 to $390 | StockAnalysis forecast and S&P Global Market Intelligence | August 4, 2026 |
| DOE HALEU contract | Signed definitive $900 million DOE contract in July 2026; total enrichment contract valued at over $1 billion including all options; intends to transition the HALEU production cascade to commercial operation | PR Newswire via StockAnalysis news feed | August 4, 2026 |
| Oklo HALEU letter of intent | Oklo and Centrus signed a letter of intent for Centrus to supply domestic HALEU to power up to five Oklo Aurora power plants | Barron's and TheFly via StockAnalysis news feed | August 4, 2026 |
| Q1 2026 earnings and upcoming report | Q1 2026 revenue $76.7 million with EPS of $0.45; Q2 2026 earnings due August 5, 2026 with a webcast on August 6 | StockAnalysis financials and PR Newswire | August 4, 2026 |
This LEU AI stock analysis is an informational research tool only. It is not investment advice, a recommendation to buy or sell Centrus Energy Corp. stock, or a guarantee of future returns. Forecast scenarios are based on available data as of August 4, 2026, can be wrong, and should be updated when new DOE contract, earnings, balance-sheet, competitive, or policy information becomes available.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
